Autism Spectrum Disorder Clinical Trials

Find Autism Spectrum Disorder Clinical Trials Near You

Sibwatch: Optimizing Intervention Options for Infants and Toddlers With a High Likelihood of Social Communication Delays and Language Disorder

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This rigorous randomized controlled trial will evaluate the efficacy and acceptability of a preemptive, telehealth intervention (tele-ImPACT) in a large, representative sample of infant siblings of autistic children, who are known to be at high likelihood of receiving a future diagnosis of autism and/or developmental language disorder (HL-Sibs). If our hypotheses are supported, this innovative and interdisciplinary study will provide empirical support for a novel approach to treatment that is theoretically motivated and developmentally informed, as well as accessible for and acceptable to families, and will lend new insights into the developmental windows in which, mechanisms by which, and subgroups for which the treatment works. Such findings would have strong implications for research, policy, theory, and practice in young children at risk for autism and/or language disorder.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6 months
Maximum Age: 2
Healthy Volunteers: f
View:

• chronological age between 6-24 months

• has at least one older biological sibling diagnosed with autism

Locations
United States
Tennessee
VUMC
RECRUITING
Nashville
Texas
Little Longhorn Lab
RECRUITING
Austin
Contact Information
Primary
Lauren Hampton, Ph.D.
Sibwatch@utexas.edu
512-471-2090
Time Frame
Start Date: 2026-04-01
Estimated Completion Date: 2032-03-31
Participants
Target number of participants: 140
Treatments
No_intervention: Business as Usual
Control arm where participants will receive community treatments, as usual.
Experimental: tele-ImPACT
Participants will receive 12 weeks of intervention
Related Therapeutic Areas
Sponsors
Leads: University of Texas at Austin

This content was sourced from clinicaltrials.gov